Safety outcomes when switching between biosimilars and reference biologics: A systematic review and meta-analysis

Biosimilars are increasingly available for the treatment of many serious disorders, however some concerns persist about switching a patient to a biosimilar whose condition is stable while on the reference biologic. Randomized controlled studies and extension studies with a switch treatment period (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Herndon, Thomas M., Ausin, Cristina, Brahme, Nina N., Schrieber, Sarah J., Luo, Michelle, Andrada, Frances C., Kim, Carol, Sun, Wanjie, Zhou, Lingjie, Grosser, Stella, Yim, Sarah, Ricci, M. Stacey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547155/
https://www.ncbi.nlm.nih.gov/pubmed/37788264
http://dx.doi.org/10.1371/journal.pone.0292231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547155/
https://www.ncbi.nlm.nih.gov/pubmed/37788264
http://dx.doi.org/10.1371/journal.pone.0292231

Ejemplares similares